The eHealth Diabetes Remission Trial - Pilot Study

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

January 29, 2022

Study Completion Date

January 29, 2022

Conditions
Type 2 Diabetes
Interventions
BEHAVIORAL

Diabetes remission using total diet replacement and eHealth contact with the healthcare provider

Participants will replace usual foods with the commercially available total diet replacement Modifast (Impolin AB), which is delivered to them during the study period without any cost. Participants will be supplied with a scale, a finger-stick blood glucose meter and a blood pressure monitor and will be advised to measure body weight, fasting blood glucose and blood pressure every morning. The results are registered in the mobile phone application Telia Health Monitoring (Telia Sweden AB) and are wirelessly transmitted to the study team.

Trial Locations (1)

90187

Department of Public Health and Clinical Medicine, Medicine, Umeå

All Listed Sponsors
collaborator

Region Västerbotten

OTHER_GOV

lead

Julia Otten

OTHER

NCT04805996 - The eHealth Diabetes Remission Trial - Pilot Study | Biotech Hunter | Biotech Hunter